Literature DB >> 33539025

Metabolic Stress and Immunity: Nutrient-Sensing Kinases and Tryptophan Metabolism.

Johanna M Gostner1, Dietmar Fuchs2, Katharina Kurz3.   

Abstract

The tryptophan catabolizing enzyme indoleamine 2,3-dioxygenase (IDO-1) has gained major attention due the immunoregulatory nature of this pathway. Both depletion of tryptophan concentrations as well as the accumulation of downstream metabolites are relevant for the mediation of the manifold consequences of increased tryptophan metabolism. Increased tryptophan catabolism is indicative for several chronic inflammatory disorders such as infections, autoimmune diseases or cancer. Low tryptophan availability is likely to be involved in the manifestation of a variety of comorbidities such as anemia, cachexia, depression and neurocognitive disturbances.Several nutrient sensing kinases are implicated in the downstream effects of dysregulated tryptophan metabolism. These include mechanisms that were conserved during evolution but have gained special features in multicellular eukaryotes, such as pathways regulated by eukaryotic translation initiation factor 2 (eIF-2)-alpha kinase (GCN2, also named general control nonderepressible 2 kinase), 5'-adenosine monophosphate (AMP)-activated protein kinase (AMPK) and target of rapamycin (TOR).The interplay between IDO-1 and above-mentioned pathway seems to be highly context dependent. A better understanding of the crosstalk is necessary to support the search for druggable targets for the treatment of inflammatory and autoimmune disorders.

Entities:  

Keywords:  5′-adenosine monophosphate (AMP)-activated protein kinase (AMPK); Eukaryotic translation initiation factor 2 (eIF-2)-alpha kinase (GCN2); General control nonderepressible 2 kinase; Indoleamine 2,3-dioxygenase (IDO-1); Kynurenine; Nutrient sensing; Target of rapamycin (TOR); Tryptophan

Mesh:

Substances:

Year:  2021        PMID: 33539025     DOI: 10.1007/978-3-030-49844-3_16

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  50 in total

1.  Design, synthesis and antitumor study of a series of N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors.

Authors:  Shulun Chen; Wei Guo; Xiaohua Liu; Pu Sun; Yi Wang; Chunyong Ding; Linghua Meng; Ao Zhang
Journal:  Eur J Med Chem       Date:  2019-06-17       Impact factor: 6.514

Review 2.  The IFN gamma receptor: a paradigm for cytokine receptor signaling.

Authors:  E A Bach; M Aguet; R D Schreiber
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 3.  Nutrient-sensing mechanisms across evolution.

Authors:  Lynne Chantranupong; Rachel L Wolfson; David M Sabatini
Journal:  Cell       Date:  2015-03-26       Impact factor: 41.582

4.  IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.

Authors:  Kumar S Bishnupuri; David M Alvarado; Alexander N Khouri; Mark Shabsovich; Baosheng Chen; Brian K Dieckgraefe; Matthew A Ciorba
Journal:  Cancer Res       Date:  2019-01-24       Impact factor: 12.701

5.  The kinase GLK controls autoimmunity and NF-κB signaling by activating the kinase PKC-θ in T cells.

Authors:  Huai-Chia Chuang; Joung-Liang Lan; Der-Yuan Chen; Chia-Yu Yang; Yi-Ming Chen; Ju-Pi Li; Ching-Yu Huang; Pao-En Liu; Xiaohong Wang; Tse-Hua Tan
Journal:  Nat Immunol       Date:  2011-10-09       Impact factor: 25.606

6.  Indoleamine 2,3-dioxygenase depletes tryptophan, activates general control non-derepressible 2 kinase and down-regulates key enzymes involved in fatty acid synthesis in primary human CD4+ T cells.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Georgia Antoniadi; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Immunology       Date:  2015-07-27       Impact factor: 7.397

Review 7.  Cellular responses to interferon-gamma.

Authors:  U Boehm; T Klamp; M Groot; J C Howard
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 8.  The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy.

Authors:  Lieve Brochez; Ines Chevolet; Vibeke Kruse
Journal:  Eur J Cancer       Date:  2017-03-18       Impact factor: 9.162

9.  Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.

Authors:  C Carnaud; D Lee; O Donnars; S H Park; A Beavis; Y Koezuka; A Bendelac
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

Review 10.  The eIF2α kinases: their structures and functions.

Authors:  Neysan Donnelly; Adrienne M Gorman; Sanjeev Gupta; Afshin Samali
Journal:  Cell Mol Life Sci       Date:  2013-01-26       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.